FDA inspection
New York Blood Center Inc: FDA inspection ending Sep 18, 2024
FDA inspection 1250223 · No Action Indicated (NAI) · New York, NY
Key facts
| Inspection ID | 1250223 |
|---|---|
| Firm | New York Blood Center Inc |
| FEI number | 3005255747 |
| Address | Grand Cent Donor Center-Chanin Bldg, 115 E 41st St |
| City | New York |
| State | NY |
| ZIP | 10017 |
| Country | United States |
| Fiscal year | 2024 |
| Inspection end date | Sep 18, 2024 |
| Classification | No Action Indicated (NAI) |
| Project area | Blood and Blood Products |
| Product type | Biologics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data